Envío gratuito y discreto a partir de 200 € - calidad testada en laboratorio

LabGain
oxyPharma

Cagrilintide OXY-CAGRI (15 mg) OxyPharma

0 opiniones de clientes
Precio bajo consulta

Cagrilintide: a new era in the fight against excess weight and diabetes Cagrilintide OXY-CAGRI 15 mg is an innovative drug from OxyPharma that opens up new opportunities in the treatment of obesity and diabetes. This drug not only works, it changes the very system of appetite control and metabolism. How Kagrilintide works: science to guard your health The action of Kagrilintide is based on a unique mechanism associated with the hormone amylin. It is an analogue of natural amylamine, which: Contr

Agotado
1
  • Referencia: cagrilintide-oxy-cagri-15-mg-oxypharma-default
  • Marca: oxyPharma
  • Categoría: Péptidos

Cagrilintide is a long-acting amylin analogue used in weight management and metabolic research, working alongside (not instead of) GLP-1 agents like semaglutide or tirzepatide. Each vial contains 15 mg of pharmaceutical-grade Cagrilintide in powder form for reconstitution, offering more doses per vial for extended protocols.

By mimicking natural amylin, Cagrilintide acts on satiety centers in the brain to create a stable feeling of fullness while slowing gastric emptying, which blunts post-meal blood sugar spikes. Combined with a GLP-1 agonist, studies report a notably stronger effect on body weight and HbA1c than either compound alone.

Key Benefits

  • Supports sustained appetite control and reduced calorie intake
  • Slows gastric emptying for longer-lasting satiety
  • Enhances weight-loss and glycemic outcomes when paired with a GLP-1 agonist
  • Higher 15 mg fill suits longer titration schedules with fewer vial changes

Opiniones (0)

Todavía no hay opiniones.

Escribir una opinión

Tu valoración

Productos relacionados